KATIE TATE: Open Payments
NPI 1720743404 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$907 in 47 payments from 10 companies in 2025. Trend: 2023 $1,572 · 2024 $1,128 · 2025 $907
Food & beverage: $907
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $237 |
| Amgen Inc. | 17 | $205 |
| AstraZeneca Pharmaceuticals LP | 2 | $135 |
| UCB, Inc. | 5 | $93 |
| ABBVIE INC. | 3 | $82 |
| Mallinckrodt Hospital Products Inc. | 2 | $47 |
| GlaxoSmithKline, LLC. | 3 | $46 |
| Sandoz Inc. | 2 | $34 |
| Inspire Medical Systems, Inc. | 1 | $14 |
| SHIELD THERAPEUTICS INC | 1 | $14 |
Products named: COSENTYX, ENBREL, AIRSUPRA, Bimzelx, OTEZLA, RINVOQ, ACTHAR, BENLYSTA.
Industry payments across NC — which companies pay providers there.
